Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: Where do we stand?

Published on Feb 24, 2021in Acta Biomaterialia7.242
· DOI :10.1016/J.ACTBIO.2021.02.030
Cong-Shan Yuan1
Estimated H-index: 1
(Ocean University of China),
Zhenwei Deng1
Estimated H-index: 1
(Ocean University of China)
+ 3 AuthorsYa Liu21
Estimated H-index: 21
(Ocean University of China)
Sources
Abstract
Abstract The past several years have witnessed the blooming of emerging immunotherapy, as well as their therapeutic potential in remodeling the immune system. Nevertheless, with the development of biological mechanisms in oncology, it has been demonstrated that hypoxic tumor microenvironment (TME) seriously impairs the therapeutic outcomes of immunotherapy. Hypoxia, caused by Warburg effect and insufficient oxygen delivery, has been considered as a primary construction element of TME and drawn tremendous attention in cancer therapy. Multiple hypoxia-modulatory theranostic agents have been facing many obstacles and challenges while offering initial therapeutic effect. Inspired by versatile nanomaterials, great efforts have been devoted to design hypoxia-based nanoplatforms to preserve drug activity, reduce systemic toxicity, provide adequate oxygenation, and eventually ameliorate hypoxic-tumor management. Besides these, recently, some curative and innovative hypoxia-related nanoplatforms have been applied in synergistic immunotherapy, especially in combination with immune checkpoint blockade (ICB), immunomodulatory therapeutics, cancer vaccine therapy and immunogenic cell death (ICD) effect. Herein, the paramount impact of hypoxia on tumor immune escape was initially described and discussed, followed by a comprehensive overview on the design tactics of multimodal nanoplatforms based on hypoxia-enabled theranostic agents. A variety of nanocarriers for relieving tumor hypoxic microenvironment were also summarized. On this basis, we presented the latest progress in the use of hypoxia-modulatory nanomaterials for synergistic immunotherapy and highlighted current challenges and plausible promises in this area in the near future. Statement of Significance : Cancer immunotherapy, emerging as a novel treatment to eradicate malignant tumors, has achieved a measure of success in clinical popularity and transition. However, over the last decades, hypoxia-induced tumor immune escape has attracted enormous attention in cancer treatment. Limitations of free targeting agents have paved the path for the development of multiple nanomaterials with the hope of boosting immunotherapy. In this review, the innovative design tactics and multifunctional nanocarriers for hypoxia alleviation are summarized, and the smart nanomaterial-assisted hypoxia-modulatory therapeutics for synergistic immunotherapy and versatile biomedical applications are especially highlighted. In addition, the challenges and prospects of clinical transformation are further discussed.
📖 Papers frequently viewed together
20206.89Nanoscale
2 Citations
13 Citations
20206.89Nanoscale
4 Authors (Shuyan Han, ..., Jun Wu)
17 Citations
References205
Newest
#1Yannan Yang (UQ: University of Queensland)H-Index: 24
#2Zhengying Gu (UQ: University of Queensland)H-Index: 10
Last. Chengzhong Yu (ECNU: East China Normal University)H-Index: 80
view all 7 authors...
MnO2 nanoparticles have been widely employed in cancer immunotherapy, playing a subsidiary role in assisting immunostimulatory drugs by improving their pharmacokinetics and/or creating a favorable microenvironment. Here, the stereotype of the subsidiary role of MnO2 nanoparticles in cancer immunotherapy is challenged. This study unravels an intrinsic immunomodulatory property of MnO2 nanoparticles as a unique nutrient-responsive immunogenic cell death (ICD) inducer, capable of directly modulatin...
4 CitationsSource
#1Lisi Xie (UM: University of Macau)H-Index: 8
#2Guohao Wang (UM: University of Macau)H-Index: 11
Last. Yunlu Dai (UM: University of Macau)H-Index: 57
view all 9 authors...
Abstract A critical challenge remains in PD-1 checkpoint blockade immunotherapy is few tumor specific T cells infiltration in hypoxic tumor microenvironment (TME). Improving immunogenic cell death (ICD) associated immunogenicity can make tumor sensitive to PD-1 checkpoint blockade immunotherapy. Herein, a phenolic ICD inducer was engineered by self-assembly of the superior ICD inducer (doxorubicin, DOX), phenolic manganese dioxide nanoreactor, ferric iron and PEG-polyphenols (MDP NPs) via metal ...
10 CitationsSource
#1Maowei JiangH-Index: 6
#2Zhanhao Hu (OIST: Okinawa Institute of Science and Technology)H-Index: 17
Last. Yabing QiH-Index: 56
view all 4 authors...
All-inorganic α-CsPbBrxI3-x perovskites featuring nano-sized crystallites show great potential for pure-red light-emitting diode (LED) applications. Currently, the CsPbBrxI3–x LEDs based on nano-sized α-CsPbBrxI3-x crystallites have been fabricated mainly via the classical colloidal route including a tedious procedure of nanocrystal synthesis, purification, ligand or anion exchange, film casting, etc. With the usually adopted conventional LED device structure, only high turn-on voltages (> 2.7) ...
7 CitationsSource
Ultrasound with deep penetration depth and high security could be adopted in sonodynamic therapy (SDT) by activating sonosensitizers to generate cytotoxic reactive oxygen species (ROS). Herein, two-dimensional (2D) coordination nanosheets composed of Zn2+ and Tetrakis(4-carboxyphenyl) porphyrin (TCPP) are fabricated. While exhibiting greatly enhanced ultrasound-triggered ROS generation useful for noninvasive SDT, such Zn-TCPP 2D nanosheets show high loading capacity of oligodeoxynucleotides such...
8 CitationsSource
#1Yuanyuan Yang (Southern Medical University)H-Index: 12
#2Xin Liu (Southern Medical University)H-Index: 7
Last. Zhiqiang Yu (Southern Medical University)H-Index: 32
view all 11 authors...
External stimuli-responsive nanomedicine with desirable repetitive on-demand drug release character is postulated to greatly accommodate patients' flexible medication regime. To this object, light-activatable liposomes (Pt/Ce6-LP) integrated with both a Ce6 photodynamic component and a tetravalent platinum prodrug (Pt(IV)) chemotherapeutic component are engineered. This multifunctional system was rationally designed using unsaturated phospholipid to achieve repetitive on-demand drug release unde...
31 CitationsSource
#1Panpan SunH-Index: 5
#2Qingqing DengH-Index: 6
Last. Xiaogang QuH-Index: 102
view all 6 authors...
Macrophages are known to penetrate tumor central hypoxic areas and hold great potential in cancer drug delivery. However, it remains a big challenge for current macrophage-based drug delivery syste...
24 CitationsSource
#1Xiaolong Liang (PKU: Peking University)H-Index: 30
#2Min Chen (PKU: Peking University)H-Index: 10
Last. Zhifei Dai (PKU: Peking University)H-Index: 54
view all 5 authors...
Photodynamic therapy (PDT) shows great promise for the treatment of colon cancer. However, practically, it is a great challenge to use a nanocarrier for the codelivery of both the photosensitizer a...
30 CitationsSource
#1Asmita Banstola (KMU: Keimyung University)H-Index: 5
#2Jee-Heon Jeong (Yeungnam University)H-Index: 26
Last. Simmyung Yook (KMU: Keimyung University)H-Index: 13
view all 3 authors...
Abstract Cancer immunotherapy evolved as a new treatment modality to eradicate tumor cells and has gained in popularity after its successful clinical transition. By activating antigen-presenting cells (APCs), and thus, inducing innate or adaptive immune responses, immunoadjuvants have become promising tools for cancer immunotherapy. Different types of immunoadjuvants such as toll-like receptor (TLR) agonists, exosomes, and metallic and plant-derived immunoadjuvants have been studied for their im...
18 CitationsSource
#1Dan Wang (UM: University of Macau)H-Index: 1
#2Bin Xue (UM: University of Macau)H-Index: 1
Last. Zhen Yuan (UM: University of Macau)H-Index: 34
view all 10 authors...
Abstract Hypoxia is one of the hallmarks of solid tumor, which heavily restricts the clinical cancer therapy treatments, especially for the oxygen (O2) -dependent photodynamic therapy (PDT). Herein, an intelligent multi-layer nanostructure was developed for decreasing the O2-consumption and elevating the O2-supply simultaneously. The cell respiration inhibitor –atovaquone (ATO) molecules were reserved in the middle mesoporous silicon layer, and thus were intelligently released at the tumor site ...
23 CitationsSource
#1Zijun Shen (Qingdao University)H-Index: 2
#2Junfei Xia (Tufts University)H-Index: 13
Last. Yong Sun (Qingdao University)H-Index: 12
view all 9 authors...
Photodynamic therapy (PDT) is a promising strategy in cancer treatment that utilizes photosensitizers (PSs) to produce reactive oxygen species (ROS) and eliminate cancer cells under specific wavelength light irradiation. However, special tumor environments, such as those with overexpression of glutathione (GSH), which will consume PDT-mediated ROS, as well as hypoxia in the tumor microenvironment (TME) could lead to ineffective treatment. Moreover, PDT is highly light-dependent and therefore can...
20 CitationsSource
Cited By0
Newest